Combination of the Vaginal Laser With a Moisturizing and Repairing Niosomal Gel in the Treatment of Genitourinary Syndrome in Oncology Patients

Launched by HOSPITAL UNIVERSITARI DE BELLVITGE · Jul 15, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a new treatment for women experiencing genitourinary syndrome due to menopause, particularly those who have a history of cancer and cannot use estrogen therapies. The study is testing the combination of vaginal laser therapy and a special moisturizing gel designed to help repair and hydrate the vaginal area. Researchers want to see if this combination can effectively relieve symptoms for women in this situation.

To participate in the trial, women aged 65 to 74 who have been diagnosed with genitourinary syndrome and have a history of cancer may be eligible. However, women with certain other conditions, like pelvic organ prolapse or additional vulvovaginal issues, cannot take part. If you join the study, you can expect to receive the treatment and participate in assessments to help determine how well it works for your symptoms. This trial is currently looking for participants, so it could be a great opportunity to find relief and contribute to important research.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patients with an established SGM diagnosis.
• • Patients with a history of neoplasia in whom the use of estrogens as the first alternative for the treatment of GMS is not recommended.
• Exclusion Criteria:
• • Patients with concomitant vulvovaginal pathology.
• • Patients with a diagnosis of pelvic organ prolapse grade II or greater.